>
Nanosonics logo

NAN - Nanosonics Share Price

A$4.96 -0.1  -1.8%

Last Trade - 1:30am

Sector
Healthcare
Size
Mid Cap
Market Cap £835.0m
Enterprise Value £787.9m
Revenue £52.0m
Position in Universe 239th / 1913
Bullish
Bearish
Unlock NAN Revenue
Momentum
Relative Strength (%)
1m -17.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -38.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
22.2 42.8 67.5 60.7 84.3 100.1 103.1 130 +35.1%
+20,130 -78.1 +135.3 -25.6 -31.0 +147.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020,Nanosonics Ltd. revenues decreased 11% to A$43.1M. Netincome decreased 74% to A$1.5M. Revenues reflect NorthAmerica segment decrease of 16% to A$36.9M. Net income alsoreflects Net foreign exchange gain/ (loss) increase fromA$655K (income) to A$3.3M (expense), Administrationexpenses increase of 23% to A$7.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NAN Revenue Unlock NAN Revenue

Net Income

NAN Net Income Unlock NAN Revenue

Normalised EPS

NAN Normalised EPS Unlock NAN Revenue

PE Ratio Range

NAN PE Ratio Range Unlock NAN Revenue

Dividend Yield Range

NAN Dividend Yield Range Unlock NAN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NAN EPS Forecasts Unlock NAN Revenue
Profile Summary

Nanosonics Ltd is an Australia-based company focused on developing automated disinfection technology. The Company’s principal activities include manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories and research, development and commercialization of infection control and decontamination products and related technologies. The Company’s automated Trophon electron paramagnetic resonance (EPR) disinfection device provides solutions for care in ultrasound probe disinfection practices. trophon is its solution for reducing cross contamination between patients and reducing the spread of Healthcare Acquired Infections (HAIs). Its trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Its consumable and accessories include NanoNebulant, trophon Chemical Indicator, trophon AcuTrace Operator Card and trophon Printer.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated November 14, 2000
Public Since May 17, 2007
No. of Shareholders: 19,077
No. of Employees: 311
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries , S&P/ASX 200 , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 301,048,442
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NAN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NAN
Upcoming Events for NAN
Frequently Asked Questions for Nanosonics
What is the Nanosonics share price?

As of 1:30am, shares in Nanosonics are trading at A$4.96, giving the company a market capitalisation of £835.0m. This share price information is delayed by 15 minutes.

How has the Nanosonics share price performed this year?

Shares in Nanosonics are currently trading at A$4.96 and the price has moved by -25.95% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nanosonics price has moved by -43.62% over the past year.

What are the analyst and broker recommendations for Nanosonics?

Of the analysts with advisory recommendations for Nanosonics, there are there are currently 1 "buy" , 3 "hold" and 2 "sell" recommendations. The overall consensus recommendation for Nanosonics is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Nanosonics next release its financial results?

Nanosonics is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Nanosonics dividend yield?

Nanosonics does not currently pay a dividend.

Does Nanosonics pay a dividend?

Nanosonics does not currently pay a dividend.

When does Nanosonics next pay dividends?

Nanosonics does not currently pay a dividend.

How do I buy Nanosonics shares?

To buy shares in Nanosonics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nanosonics?

Shares in Nanosonics are currently trading at A$4.96, giving the company a market capitalisation of £835.0m.

Where are Nanosonics shares listed? Where are Nanosonics shares listed?

Here are the trading details for Nanosonics:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: NAN
What kind of share is Nanosonics?

Based on an overall assessment of its quality, value and momentum, Nanosonics is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nanosonics share price forecast 2021?

Shares in Nanosonics are currently priced at A$4.96. At that level they are trading at 4.79% discount to the analyst consensus target price of 0.00.

Analysts covering Nanosonics currently have a consensus Earnings Per Share (EPS) forecast of 0.023 for the next financial year.

How can I tell whether the Nanosonics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nanosonics. Over the past six months, the relative strength of its shares against the market has been -27.56%. At the current price of A$4.96, shares in Nanosonics are trading at -19.92% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nanosonics PE Ratio?

The Nanosonics PE ratio based on its reported earnings over the past 12 months is 0.261k. The shares are currently trading at A$4.96.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Nanosonics?

Nanosonics's management team is headed by:

Maurie Stang - NEC
David Fisher - NID
McGregor Grant - CFO
Michael Kavanagh - PRE
Steven Sargent - NVC
Marie Elizabeth McDonald - NID
Steven Farrugia - CTO
Renee Salaberry - CMO
David Morris - CEX
Rod Lopez - COO
Geoff Wilson - NED
Ken Shaw - CEX
Jodi Sampson - EXO
Ronan Wright - CEX
Who are the major shareholders of Nanosonics?

Here are the top five shareholders of Nanosonics based on the size of their shareholding:

Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 9.88% (29.7m shares)
Fidelity Select Medical Technology and Devices Portfolio Mutual Fund
Percentage owned: 7.24% (21.8m shares)
Stang (Maurie) Individual Investor
Percentage owned: 6.29% (18.9m shares)
Stang (Bernard) Individual Investor
Percentage owned: 5.41% (16.3m shares)
Macquarie Investment Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 4.66% (14.0m shares)
Similar to NAN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.